Salesforce (CRM) Stock Forecast & Price Target

Q: What analysts cover Salesforce?

Salesforce has been rated by research analysts at Argus , Barclays , BMO Capital Markets , BTIG Research , Canaccord Genuity Group , Cantor Fitzgerald , Citigroup , Citizens Jmp , CLSA , DA Davidson , Deutsche Bank Aktiengesellschaft , Erste Group Bank , Evercore , Guggenheim , HC Wainwright , Jefferies Financial Group , JPMorgan Chase & Co. , KeyCorp , Mizuho , Monness Crespi & Hardt , Morgan Stanley , Needham & Company LLC , Oppenheimer , Phillip Securities , Raymond James Financial , Royal Bank Of Canada , Sanford C. Bernstein , Scotiabank , Susquehanna , TD Cowen , The Goldman Sachs Group , Truist Financial , UBS Group , Wedbush , Weiss Ratings , Wells Fargo & Company , and Wolfe Research in the past 90 days.

$264.13 +7.20 (+2.80%)

As of 03:58 PM Eastern

Compare

Salesforce - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 48 Analyst Ratings

Sell
3

Hold
15

Buy
30

Based on 48 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 48 analysts, 3 have given a sell rating, 15 have given a hold rating, 27 have given a buy rating, and 3 have given a strong buy rating for CRM.

Consensus Price Target

$266.50
0.90% Upside

According to the 48 analysts' twelve-month price targets for Salesforce, the average price target is $266.50. The highest price target for CRM is $400.00, while the lowest price target for CRM is $160.00. The average price target represents a forecasted upside of 0.90% from the current price of $264.13.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRM Analyst Ratings Over Time

Type	Current Forecast 9/3/25 to 9/3/26	1 Month Ago 8/4/25 to 8/4/26	3 Months Ago 6/5/25 to 6/5/26	1 Year Ago 9/3/24 to 9/3/25
Strong Buy	3 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	27 Buy rating(s)	24 Buy rating(s)	27 Buy rating(s)	24 Buy rating(s)
Hold	15 Hold rating(s)	16 Hold rating(s)	10 Hold rating(s)	10 Hold rating(s)
Sell	3 Sell rating(s)	4 Sell rating(s)	2 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$266.50	$249.51	$259.26	$341.50
Forecasted Upside	0.90% Upside	30.62% Upside	39.50% Upside	32.95% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Salesforce Stock vs. The Competition

Type	Salesforce	Technology Companies	Broader Market
Consensus Rating Score	2.63	2.23	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	0.35% Upside	373.10% Upside	13.76% Upside
News Sentiment Rating	Positive News See Recent CRM News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
9/2/2026	Morgan Stanley 3 of 5 stars	Keith Weiss 2 of 5 stars	Set Target		$315.00	+22.09%
9/2/2026	Needham & Company LLC 4 of 5 stars	Scott Berg 1 of 5 stars	Reiterated Rating	Buy	$400.00	+57.05%
9/2/2026	BTIG Research 3 of 5 stars	Allan Verkhovski Not Rated	Reiterated Rating	Buy	$300.00	+16.28%
9/2/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew VanVliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$250.00 ➝ $300.00	+16.28%
8/31/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Bonner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$290.00 ➝ $300.00	+16.91%
8/27/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Sector Perform	$210.00 ➝ $250.00	+2.56%
8/27/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$240.00 ➝ $280.00	+14.87%
8/27/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
8/27/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Strong-Buy
8/27/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
Get the Latest News and Ratings for CRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Salesforce and its competitors with MarketBeat's FREE daily newsletter.
8/27/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
8/27/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$228.00	+10.67%
8/27/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$250.00 ➝ $275.00	+12.82%
8/27/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$236.00 ➝ $276.00	+33.97%
8/27/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$250.00 ➝ $300.00	+45.62%
8/27/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$175.00 ➝ $200.00	-2.92%
8/27/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform
8/27/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Strong-Buy
8/27/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$204.00 ➝ $233.00	-8.30%
8/27/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$250.00 ➝ $265.00	+5.25%
8/27/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$250.00 ➝ $265.00	+5.60%
8/27/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$210.00 ➝ $240.00	-3.06%
8/27/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$230.00 ➝ $260.00	+6.66%
8/27/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$205.00 ➝ $230.00	-4.99%
8/27/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry Tillman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$280.00 ➝ $300.00	+45.62%
8/27/2026	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian White Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$222.00 ➝ $266.00	+29.12%
8/25/2026	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$225.00	+7.56%
8/25/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform	$315.00	+50.58%
8/12/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Sell (D+) ➝ Hold (C-)
8/5/2026	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Buy
7/20/2026	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bhavtosh Vajpayee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Hold	$165.00	-3.62%
7/8/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jackson Ader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Overweight ➝ Sector Weight
7/1/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform
7/1/2026	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Neutral
6/29/2026	Phillip Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold	$253.00 ➝ $166.00	+4.91%
6/18/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Sector Outperform ➝ Sector Perform
6/18/2026	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Negative
6/2/2026	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$295.00 ➝ $280.00	+53.24%
5/29/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$350.00 ➝ $356.00	+86.39%
5/28/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Overweight ➝ Neutral
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad) The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions. See the 5 stocks to avoid
5/28/2026	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$325.00	+82.72%
5/28/2026	Macquarie Infrastructure Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Koenig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$200.00 ➝ $190.00	+5.84%
5/28/2026	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Ellis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$205.00 ➝ $240.00	+33.36%
5/18/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tal Liani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy ➝ Underperform	$160.00	-7.93%
3/10/2026	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nehal Chokshi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Market Perform	$267.00 ➝ $229.00	+15.24%
2/26/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$300.00 ➝ $250.00	+27.84%
12/11/2025	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
12/4/2025	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$325.00 ➝ $315.00	+32.09%
5/30/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$311.00 ➝ $309.00	+16.88%
5/28/2025	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Shauger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$320.00	+15.55%
2/27/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yun Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Hold	$330.00 ➝ $300.00	+0.80%
2/19/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Omar Sheikh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy
10/17/2024	Cfra Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Siegel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$343.00	+16.88%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:46 PM ET.

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 1, 2026. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

Salesforce, Inc. reported a significant beat in its most recent quarter, with actual earnings per share of $5.90 compared to a consensus estimate of $3.27, demonstrating strong profitability and operational efficiency that has driven investor confidence.
The company's artificial intelligence initiatives are generating substantial revenue, with Agentforce annual recurring revenue increasing 200% to $1.5 billion and total AI and data ARR rising more than 200% to $3.9 billion, indicating rapid adoption of its new agentic workflows.
Management raised its full-year fiscal 2027 revenue guidance to a range of $46.1 billion to $46.4 billion, signaling strong future growth expectations and reinforcing the company's position as a leader in enterprise software.
Customer retention remains robust, with churn falling to near-record lows and more than 10,000 customers now using at least one Salesforce AI product, suggesting that the platform is successfully integrating AI without disrupting existing customer relationships.
The stock is currently trading at $258.00, which is below the 52-week high of $269.11, offering a potential entry point for investors who believe the recent rally driven by AI adoption has not yet fully priced in the company's long-term value.

Salesforce
Bear Case

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

The stock's recent surge has pushed the relative strength index above 80, a technical indicator that suggests the asset is overbought and may be due for a price correction or consolidation period.
The company's price-to-earnings ratio stands at 23.52, which is relatively high and may limit upside potential if future earnings growth does not continue to accelerate at the pace seen in the most recent quarter.
Some analysts, such as Northland Securities, have recently lowered their earnings per share estimates for upcoming quarters, reflecting caution about the sustainability of the recent revenue growth and the challenges of scaling AI product adoption.
The shift toward outcome-based pricing and consumption models introduces complexity for customers and may lead to unpredictable revenue streams if adoption of these new pricing structures does not meet management's expectations.
The company faces intense competition in the AI space, with the need to continuously integrate new models and partners, such as Anthropic, which could dilute margins or require significant ongoing investment to maintain its competitive edge.

CRM Forecast - Frequently Asked Questions

According to the research reports of 48 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $266.50, with a high forecast of $400.00 and a low forecast of $160.00.

48 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last year. There are currently 3 sell ratings, 15 hold ratings, 27 buy ratings and 3 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CRM shares.

According to analysts, Salesforce's stock has a predicted upside of 0.90% based on their 12-month stock forecasts.

Over the previous 90 days, Salesforce's stock had 10 downgrades and 9 upgrades by analysts.

Salesforce has been rated by research analysts at Argus, Barclays, BMO Capital Markets, BTIG Research, Canaccord Genuity Group, Cantor Fitzgerald, Citigroup, Citizens Jmp, CLSA, DA Davidson, Deutsche Bank Aktiengesellschaft, Erste Group Bank, Evercore, Guggenheim, HC Wainwright, Jefferies Financial Group, JPMorgan Chase & Co., KeyCorp, Mizuho, Monness Crespi & Hardt, Morgan Stanley, Needham & Company LLC, Oppenheimer, Phillip Securities, Raymond James Financial, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, Susquehanna, TD Cowen, The Goldman Sachs Group, Truist Financial, UBS Group, Wedbush, Weiss Ratings, Wells Fargo & Company, and Wolfe Research in the past 90 days.

Analysts like Salesforce more than other "technology" companies. The consensus rating for Salesforce is Moderate Buy while the average consensus rating for "technology" companies is Hold. Learn more on how CRM compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Salesforce Recommendations

MarketBeat monitors more than a dozen sources for Salesforce analyst ratings, with the most recent rating issued on 9/2/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Salesforce (CRM) Stock Forecast & Price Target